HOWL
Werewolf Therapeutics, Inc.Company with tickers: HOWL
CIK
1785530
CUSIP
95075A107
Shares Outstanding
48,596,817
13F Activity (30d)
12 filings
12 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Reportable Segment | $19,943,000 | $1,885,000 | $0 |